Bausch & Lomb recalls Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of Valeant Ph…
- Recall date
- June 17, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1396-2019
- FDA classification
- Class III
- Brand / firm
- Bausch & Lomb
- Sold / distributed
- Nationwide in the U.S.
Why it was recalled
Failed Stability Specifications: Out of specification for viscosity.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, NDC 24208-503-07.
Get recall alerts
Free email alert whenever Bausch & Lomb has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bausch & Lomb